Ligand-specific contribution of the N terminus and E2-loop to pharmacological properties of the histamine H1-receptor

Journal of Pharmacology and Experimental Therapeutics

Volumn 326, Issue 3, 2008, Pages 783-791

  Straßer, Andrea ^a   Wittmann, Hans Joachim ^a   Seifert, Roland ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; G PROTEIN COUPLED RECEPTOR; GUANOSINE TRIPHOSPHATASE; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR AGONIST; HISTAPRODIFEN; MEPYRAMINE; PHENOPRODIFEN; PHENYLHISTAMINE; RHODOPSIN; TRITIUM; UNCLASSIFIED DRUG; HISTAMINE H1 RECEPTOR ANTAGONIST; LIGAND;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING COMPETITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG BINDING SITE; DRUG POTENCY; DRUG STRUCTURE; GUINEA PIG; IMMUNOBLOTTING; INSECT CELL; LIGAND BINDING; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; SPECIES DIFFERENCE; WILD TYPE; ANALOGS AND DERIVATIVES; ANIMAL; BINDING SITE; BOVINAE; CELL LINE; CHEMISTRY; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECTS; HUMAN; INSECT; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN MOTIF; PROTEIN TERTIARY STRUCTURE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CATTLE; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HUMANS; INSECTS; LIGANDS; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, HISTAMINE H1;

EID: 53849126868     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.140913     Document Type: Article

References (36)

1. Ballesteros JA, Shi L, and Javitch JA (2001) Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. Mol Pharmacol 60:1-19.
2. Bruysters M, Pertz HH, Teunissen A, Bakker RA, Gillard M, Chatelain P, Schunack W, Timmerman H, and Leurs R (2004) Mutational analysis of the histamine H1-receptor binding pocket of histaprodifens. Eur J Pharmacol 487:55-63.
3. Bruysters M, Jongejan A, Gillard M, van de Manakker F, Bakker RA, Chatelain P, and Leurs R (2005) Pharmacological differences between human and guinea pig histamine H1 receptors: Asn84 (2.61) as a key residue within an additional binding pocket in the H1 receptor. Mol Pharmacol 67:1045-1052.
4. Cheng Y and Prusoff WH (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
5. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, et al. (2007) High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor. Science 318:1258-1265.
6. Elz S, Kramer K, Pertz HH, Detert H, ter Laak AM, Kühne R, and Schunack W (2000) Histaprodifens: synthesis, pharmacological in vitro evaluation, and molecular modeling of a new class of highly active and selective histamine H1-receptor agonists. J Med Chem 43:1071-1084.
7. Fitzsimons CP, Monczor F, Fernández N, Shayo C, and Davio C (2004) Mepyramine, a histamine H1 receptor inverse agonist, binds preferentially to a G protein coupled form of the receptor and sequesters G protein. J Biol Chem 279:34431-34439.
8. Foord SM, Bonner TI, Neubig RR, Rosser EM, Pin JP, Davenport AP, Spedding M, and Harmar AJ (2005) International Union of Pharmacology. XLVI. G protein-coupled receptor list. Pharmacol Rev 57:279-288.
9. Gillard M, Van Der Perren C, Moguilevsky N, Massingham R, and Chatelain P (2002) Binding characteristics of cetirizine and levocetirizine to human H 1 histamine receptor: contribution of Lys191 and Thr 194. Mol Pharmacol 61:391-399.
10. Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, Schunack W, Levi R, and Haas HL (1997) International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 49:253-278.
11. Houston C, Wenzel-Seifert K, Bürckstümmer T, and Seifert R (2002) The human histamine H2-receptor couples more efficiently to Sf9 insect cell Gs-proteins than to insect cell Gq- proteins: limitations of Sf9 cells for the analysis of receptor/G q-protein coupling. J Neurochem 80:678-696.
12. Jongejan A and Leurs R (2005) Delineation of receptor-ligand interactions at the human histamine H1 receptor by a combined approach of site-directed mutagenesis and computational techniques - or - how to bind the H1 receptor. Arch Pharm (Weinheim) 338:248-259.
13. Kim J, Jiang Q, Glashofer M, Yehle S, Wess J, and Jacobson KA (1996) Glutamate residues in the second extracellular loop of the human A2a adenosine receptor are required for ligand recognition. Mol Pharmacol 49:683-691.
14. Kristiansen K (2004) Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol Ther 103:21-80.
15. Laurila JM, Xhaard H, Ruuskanen JO, Rantanen MJ, Karlsson HK, Johnson MS, and Scheinin M (2007) The second extracellular loop of α2A- adrenoceptors contributes to the binding of yohimbine analogues. Br J Pharmacol 151:1293-1304.
16. Leurs R, Smit MJ, Tensen CP, Ter Laak AM, and Timmerman H (1994) Site-directed mutagenesis of the histamine H1-receptor reveals a selective interaction of asparagine207 with subclasses of H 1-receptor agonists. Biochem Biophys Res Commun 201:295-301.
17. Leurs R, Smit MJ, Meeder R, Ter Laak AM, and Timmerman H (1995) Lysine200 located in the fifth transmembrane domain of the histamine H1 receptor interacts with histamine but not with all H1 agonists. Biochem Biophys Res Commun 214:110-117.
18. Menghin S, Pertz HH, Kramer K, Seifert R, Schunack W, and Elz S (2003) Nα-Imidazolylalkyl and pyridylalkyl derivatives of histaprodifen: synthesis and in vitro evaluation of highly potent histamine H1-receptor agonists. J Med Chem 46:5458-5470.
19. Nonaka H, Otaki S, Ohshima E, Kono M, Kase H, Ohta K, Fukui H, and Ichimura M (1998) Unique binding pocket for KW-4679 in the histamine H 1 receptor. Eur J Pharmacol 345:111-117.
20. Ohta K, Hayashi H, Mizuguchi H, Kagamiyama H, Fujimoto K, and Fukui H (1994) Site-directed mutagenesis of the histamine H1 receptor: roles of aspartic acid107, asparagines198 and threonine 194. Biochem Biophys Res Commun 203:1096-1101.
21. Olah ME, Jacobson KA, and Stiles GL (1994) Role of the second extracellular loop of adenosine receptors in agonist and antagonist binding. Analysis of chimeric A1/A3 adenosine receptors. J Biol Chem 269:24692-24698.
22. Oostenbrink C, Villa A, Mark AE, and van Gunsteren WF (2004) A biomolecular force field based on the free enthalpy of hydration and solvation: the GROMOS force-field parameter sets 53A5 and 53A6. J Comput Chem 25:1656-1676.
23. Preuss H, Ghorai P, Kraus A, Dove S, Buschauer A, and Seifert R (2007) Point mutations in the second extracellular loop of the histamine H2 receptor do not affect the species-selective activity of guanidine-type agonists. Naunyn Schmiedebergs Arch Pharmacol 376:253-264.
24. Rasmussen SGF, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC, Burghammer M, Ratnala VRP, Sanishvili R, Fischetti RF, et al. (2007) Crystal structure of the human β2 adrenergic G-protein-coupled receptor. Nature 450:383-387.
25. Rosenbaum DM, Cherezov V, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Yao XJ, Weis WI, Stevens RC, et al. (2007) GPCR engineering yields high-resolution structural insights into β2-adrenergic receptor function. Science 318:1266-1273.
26. Scarselli M, Li B, Kim SK, and Wess J (2007) Multiple residues in the second extracellular loop are critical from M3 muscarinic acetylcholine receptor activation. J Biol Chem 282:7385-7396.
27. Seifert R and Wenzel-Seifert K (2002) Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch Pharmacol 366:381-382.
28. Seifert R, Wenzel-Seifert K, Bürckstümmer T, Pertz HH, Schunack W, Dove S, Buschauer A, and Elz S (2003) Multiple differences in agonist and antagonist pharmacology between human and guinea pig histamine H 1-receptor. J Pharmacol Exp Ther 305:1104-1115.
29. Shi L and Javitch JA (2002) The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop. Annu Rev Pharmacol Toxicol 42:437-467.
30. Shi L and Javitch JA (2004) The second extracellular loop of the dopamine D2 receptor lines the binding-site crevice. Proc Natl Acad Sci U S A 101:440-445.
31. Straßer A and Wittmann HJ (2007) Analysis of the activation mechanism of the guinea-pig Histamine H1-receptor. J Comput Aided Mol Des 21:499-509.
32. Straßer A, Striegl B, Wittmann HJ, and Seifert R (2008) Pharmacological profile of histaprodifens at four recombinant histamine H 1 receptor species isoforms. J Pharmacol Exp Ther 324:60-71.
33. Striegl B (2006) Synthese und funktionelle in-Vitro Pharmakologie neuer Histamin-H1-Rezeptoragonisten aus der Suprahistaprodifen- Reihe. Ph.D. dissertation, University of Regensburg, Regensburg, Germany.
34. van der Spoel D, Lindahl E, Hess B, van Buuren AR, Apol E, Meulenhoff PF, Tieleman DP, Sijbers ALTM, Feenstra KA, and van Drunen R, et al. (2004) Gromacs, Department of Biophysical Chemistry, University of Groningen, The Netherlands.
35. Wieland K, Ter Laak AM, Smit MJ, Kühne R, Timmerman H, and Leurs R (1999) Mutational analysis of the antagonist-binding site of the histamine H1 receptor. J Biol Chem 274:29994-30000.
36. Zhao MM, Hwa J, and Perez DM (1996) Identification of critical extracellular loop residues involved in α1-adrenergic receptor subtype-selective antagonist binding. Mol Pharmacol 50:1118-1126.